In this Healio Video Perspective, Michael A. Singer, MD, discusses promising results for migaldendranib for the treatment of ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Nanoscope Therapeutics Inc., a biotech company committed to restoring vision in blind patients in real-world settings by developing and commercializing novel gene therapies for retinal degenerative ...

Intravitreal aflibercept 2 mg regimen is linked with long-term visual acuity improvements in macular edema following CRVO.

A monitoring protocol can detect intraocular inflammation early and enable favorable visual outcomes in patients being treated for AMD.

Researcher works with universities of California-Davis, Illinois, Wisconsin and others to engineer and test a novel microsphere-hydrogel delivery for medicine, requiring fewer injections, to treat a c ...

Intravitreal injections with anti-VEGF biological treatments (anti-angiogenic therapies that target VEGF) are first-line therapy for treating and stabilizing exudative neovascular AMD (nAMD).

4D-150 is a potential backbone therapy that is designed to provide multi-year sustained delivery of anti-VEGF (aflibercept and anti-VEGF-C) from the retina with a single, safe, intravitreal injection.

The subretinal injection technique is an important intraocular drug ... It is straightforward to learn and requires minimal equipment and preparation. Typically, between 10 to 30 eyes can be injected ...

China’s central bank is boosting cash injection via one of its policy tools as it seeks to safeguard the world’s second-largest economy from the impact of punitive US tariffs. The People’s ...

The identified batches include the Lumidol injection, batch Numbers CM4594007, CM4594008, and CM4594009. The drug was manufactured by KamlaAmrut Pharmaceutical in India. The Pharmacy and Poisons Board ...